UPS Launches Chatbot And Accelerates On Path Toward Use Of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
UPS Launches Chatbot And Accelerates On Path Toward Use Of Artificial Intelligence
    ATLANTA, Nov. 21, 2016 (GLOBE NEWSWIRE) --
  • UPS chatbot available via Facebook Messenger, Skype and Amazon
  • Launch sets direction for integration of artificial intelligence into additional customer-facing technologies
  • Future updates planned, including integration with UPS My Choice service

UPS (NYSE: UPS ) on Monday said it has launched a beta version of a chatbot, an artificial-intelligence-enabled platform that mimics human conversation to help users easily find UPS ® locations, get shipping rates and track packages.

The UPS chatbot, available through Facebook Messenger, Skype and Amazon platforms, provides users with a convenient and conversational interface that is different from those offered on the UPS website or UPS mobile apps. For example, UPS customers can use simple phrases like “shipping rates” to get prompt voice responses in English. Amazon users can access the UPS chatbot through Amazon’s virtual assistant Alexa, which features voice-recognition capabilities.

“At UPS, we’re bringing our first chatbot to life to make it easier for our customers to access information about their packages and shipments through messaging apps and voice-enabled platforms,” said Stuart Marcus, UPS vice president of customer technology marketing. “Our long-range plans are much bigger than that. We see chatbots becoming an important communication channel for our customers over the next few years, and we’re setting the stage for the incorporation of artificial intelligence throughout our customer-facing technologies.”

UPS, which invests more than $1 billion a year in technology, developed its chatbot in-house and plans to continue to update its functionality, including integration with the UPS My Choice ® platform. With the addition of UPS My Choice service, customers will be able to manage the delivery time and location of incoming packages through this conversational user interface.

Elements of artificial intelligence are becoming a bigger part of various UPS technologies. For example, the company’s new virtual assistant on UPS.com uses natural language understanding to help customers track packages. The assistant becomes more skilled at its tasks as more people ask it questions.

“The UPS chatbot and the upcoming integration with UPS My Choice service exemplify the company’s dedication to customer-service enhancements,” said Andrew Van Beek, UPS senior director of applications development.

UPS My Choice members receive an email or text message the day before a shipment arrives. If they won’t be home to receive a package, they can re-route eligible packages to their workplace, a neighbor’s home or a nearby UPS Access Point ™ location. More than 30 million people now use the service in 15 countries. In the U.S., roughly one in four households are UPS My Choice users.

About UPS

UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including transporting packages and freight; facilitating international trade, and deploying advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the web at  ups.com and its corporate blog can be found at  longitudes.ups.com . To get UPS news direct, visit  pressroom.ups.com/RSS or follow @UPS_News .

Kyle Peterson 404-828-4626 kylepeterson@ups.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles